Thanks for another great informative summary post QualityStocks. In all the due diligence I have done on this company since it was recommended to me over a year ago, the only negative I have EVER been able to uncover has been their Balance Sheet/Capitalization. I've never seen anything negative on their science. Since a possible licensing deal could come with an upfront cash payment to Advaxis, it's very possible the ONLY NEGATIVE could be eliminated in the very near term. I believe that would lead to a dramatic revaluation upwards in the company's market cap. Thanks again.